Site icon OncologyTube

What Differeniates Brentuximab Vedotin From Other Treatment Options

Lorenz Trumper, MD, Professor of Internal Medicine and Chairman of the Department of Hematology and Oncology, Georg August University of Göttingen, discusses What Differeniates Brentuximab Vedotin From Other Treatment Options. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com

Exit mobile version